Arkolith/Insider Trading/DNTH/Form 4

Veness Adam M

SVP, General Counsel and Sec.Dianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)30K$17.88$536K30K
Jun 17, 2026Sell(S)17K$80.34$1.3M13K
Jun 17, 2026Sell(S)13K$81.38$1.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)30K—$080K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001778623-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML